Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2257 per EA under NDC 68180049301. Its NADAC has been published 378 times since Apr 3, 2019.
Strength
50 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180049301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209294On Market Since
2/4/2019
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 378 times since Apr 3, 2019, and over the history we have for it it has declined 93.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2257 per EA |
|---|---|
| All-time high | $4.2239 (Feb 12, 2020) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.4474 |
| Average price | $1.2624 |
| Largest weekly change | -56.5% (Nov 23, 2022) |
| Weeks tracked | 378 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Clomipramine Hydrochloride Capsules market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.2257 per EA (NDC 68180049301), effective Jun 24, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 93.3%. It has been tracked across 378 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Apr 3, 2019, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $4.2239 (Feb 12, 2020), with a median of $0.4474 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLOMIPRAMINE 50 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 68180049301) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification